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Mixed lineage leukemia (MLL) fusion proteins cause
oncogenic transformation of hematopoietic cells by
constitutive recruitment of elongation factors to
HOX promoters, resulting in overexpression of target
genes. The structural basis of transactivation byMLL
fusion partners remains undetermined. We show
that the ANC1 homology domain (AHD) of AF9, one
of the most common MLL translocation partners, is
intrinsically disordered and recruits multiple tran-
scription factors through coupled folding and bind-
ing. We determined the structure of the AF9 AHD
in complex with the elongation factor AF4 and
show that aliphatic residues, which are conserved
in each of the AF9 binding partners, form an integral
part of the hydrophobic core of the complex. Nuclear
magnetic resonance relaxation measurements show
that AF9 retains significant dynamic behavior which
may facilitate exchange between disordered part-
ners. We propose that AF9 functions as a signaling
hub that regulates transcription through dynamic
recruitment of cofactors in normal hematopoiesis
and in acute leukemia.
INTRODUCTION
Chromosomal translocations involving the mixed lineage
leukemia (MLL) gene are responsible for a subset of acute
leukemias characterized by poor prognosis and early relapse
(Dimartino and Cleary, 1999). The majority result in expression
of oncogenic fusion proteins, which include the N-terminal chro-
matin-targeting domains of the MLL protein fused to one of over
60 translocation partners (Meyer et al., 2009). Through constitu-
tive recruitment of elongation factors, these proteins upregulate
transcription of MLL target genes, including HOXA9 andMEIS1,
resulting in oncogenic transformation of hematopoietic cells.
Despite the large number of fusion partners, the five most
common account for 80% of cases and are thought to share
a common mechanism of transactivation.
The normal MLL protein regulates transcription of many
genes but is specifically required for H3K4 trimethylation and176 Structure 21, 176–183, January 8, 2013 ª2013 Elsevier Ltd All rigtranscriptional initiation at a subset of HOX promoters (Guen-
ther et al., 2005). Following initiation at these promoters, RNA
polymerase II (PolII) is subject to promoter proximal pausing.
The major regulatory step in HOX gene expression is through
release of RNA PolII from this paused state (Chopra et al.,
2009). This requires coordinated chromatin remodeling, phos-
phorylation of pause factors, and phosphorylation of serine 2
of the RNA PolII C-terminal domain by P-TEFb (Marshall et al.,
1996; O’Brien et al., 1994).
Among the most common MLL translocation partners are
AF9 and ENL, closely related members of the YEATS domain
superfamily. Both proteins have previously been identified as
components of biochemically isolated complexes with functions
in transcriptional elongation such as super elongation complex
(SEC) (Lin et al., 2010), AF4-ENL-P-TEFb complex (AEP)
(Yokoyama et al., 2010), and Dot1 complex (Dot-Com) (Mohan
et al., 2010). AF9 and ENL are able to recruit and activate
P-TEFb through recruitment of AF4 family members via their
ANC1 homology domain (AHD). Disruption of the AF4-AF9
interaction results in necrotic cell death in several cell lines
harboring MLL translocations, suggesting that the AF9 AHD
may be an attractive pharmacological target (Palermo et al.,
2008). In addition to AF4, the AHD also binds to Dot1L, a histone
methyltransferase that methylates H3K79, a histone modifica-
tion associated with transcriptional elongation (Steger et al.,
2008). Paradoxically, this domain was also shown to recruit the
BCL6 corepressor (BCoR) and Polycomb 3 (hPC3/CBX8), which
are involved in transcriptional repression (Ba´rdos et al., 2000;
Huynh et al., 2000).
It was recently demonstrated that AEP components colocalize
with MLL at a subset of promoters, suggesting that AF9 or ENL
may be recruited to these loci in a context-dependent manner to
regulate transcriptional elongation downstream of MLL. This
hypothesis is supported by recently identified interactions
between the AF9 and ENL YEATS domains and the PAF elonga-
tion complex (PAF-c) (He et al., 2011), which, in turn, interacts
with the MLL CXXC domain and flanking regions (Milne et al.,
2010; Muntean et al., 2010). These results raise the possibility
that AF9 or ENL may be recruited by both normal MLL and
MLL fusion proteins through interactions with PAF-c and that
transcriptional elongation may be regulated through interactions
of transcription factors with the AHD.
The importance of the AHD in both transcriptional regulation
and in acute leukemia has been established; however, thehts reserved
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Figure 1. The AF9 AHD Is Intrinsically Disor-
dered and Folds upon Binding to AF4
(A and B) [15N-1H] HSQC of AF9 490-568 (A) and
[15N-1H] HSQC of AF9 490-568 (B) saturated with
unlabeled AF4 761-774.
(C) Far-UV Circular dichroism spectrum of the
constructs shown in (A) and (B), Black line repre-
sents AF9 only; red line represents AF9 with AF4
peptide.
(D) Alignment of AF4 family members. Conserved
residues are in red; the AF4 peptide is underlined.
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AF9 AHD Is an Intrinsically Disordered Switchstructural basis of its function has not been demonstrated.
Here, we present the structure of the AF9 AHD in complex
with a peptide from the elongation factor AF4. We show that
this domain is intrinsically disordered in isolation and interacts
with each of its binding partners through mutual synergistic
folding. The relatively extensive intermolecular interface gener-
ated in this complex maintains high affinity binding while accom-
modating significant conformational entropy. This may allow
exchange between binding partners in response to changes in
local concentrations or posttranslational modifications, which
may be essential to dynamic transcriptional control.
RESULTS
The AF9 AHD Is Intrinsically Disordered and Interacts
with AF4 by Mutual Synergistic Folding
We expressed the C-terminal 79 amino acids of AF9, which
include theminimal portion of AF9 required for oncogenic activity
of an MLL-AF9 fusion protein in colony-forming assays (Prasad
et al., 1995) and roughly corresponds to the minimal domain
observed in a clinical case of leukemia with an MLL-AF9 translo-
cation (Mitterbauer et al., 1999). During initial efforts to express
and purify the AHD, we found that it had limited solubility
and that the domain was prone to proteolytic degradation.
[15N-1H] heteronuclear single quantum coherence spectroscopy
(HSQC) spectra showed extreme broadening, with only a small
number of peaks with narrow [1H] chemical shift dispersion
and an insufficient number of peaks for the amino acids in the
domain (Figure 1A). Since the interacting regions between AF4
and AF9 had been finely mapped (Srinivasan et al., 2004), we
titrated a peptide derived from the AF9 interaction motif of AF4
(residues 761 to 774) into the AF9 AHD. This resulted in dramat-
ically improved chemical shift dispersion and an increased
number of observable peaks in the HSQC spectrum (Figure 1B).
In order to understand the structural changes induced byStructure 21, 176–183, January 8, 2013peptide binding, we conducted circular
dichroism (CD) experiments on the AF9
AHD alone and in complex with the AF4
peptide. It is surprising that these showed
that, in isolation, the AHD is almost
entirely random coil with only a small
amount of beta structure predicted using
K2D (Andrade et al., 1993) (Figure 1C).
Upon addition of the AF4 peptide, the
domain undergoes a structural rearrange-ment to form a mixed alpha-beta structure consistent with the
dramatic change in the HSQC spectrum (Figure 1B). These
data show that the AF9 AHD is intrinsically disordered and
recruits AF4 through mutual synergistic folding (Demarest
et al., 2002).
Structure of the AF4-AF9 Complex
In order to understand the structural basis for AF9 AHD function,
we determined the structure of the AF4-AF9 complex using
nuclear magnetic resonance (NMR) spectroscopy (Protein Data
Bank [PDB] ID code 2LM0 and Biological Magnetic Resonance
Bank [BMRB] ID code 18094; Table 1). Due to the problems
encountered in expression and purification of the AF9 AHD, we
generated a construct which included 43 amino acids of AF4
fused to the flexible residues immediately preceding the AF9
AHD. This approach resulted in expression of a monomeric
homogeneous complex and yielded high quality spectra suitable
for structure determination.
The AF4-AF9 complex forms a mixed alpha-beta structure
with the AF4 residues forming an integral part of the hydrophobic
core of the complex (Figures 2A–2D; Molecular Structure S1). A
search on the Dali server indicated that this synergistically folded
complex represents a fold that has not been observed previ-
ously. [1H-15N] heteronuclear nuclear Overhauser effect (NOE)
experiments show that AF4 residues 761–775 are ordered in
the complex, whereas the remainder is flexible (Figure 4B). It is
important to note that the linker region between AF4 and AF9
is also flexible. The beta structure evident in the CD spectrum
of the isolated AHD appears to be due to the presence of
a beta-hairpin formed by AF9 residues 535–546. AF4 residues
761–766 form a b strand that extends the AF9 b-hairpin to
a three-stranded antiparallel b sheet. The rest of the AF9 domain
folds around the AF4 peptide in the form of 3 a helices, with five
C-terminal residues remaining flexible. Immediately C-terminal
to the AF4 strand is a conserved LXXLmotif (L767–L770) (Figuresª2013 Elsevier Ltd All rights reserved 177
Table 1. NMR and Refinement Statistics for the AF4-AF9
Complex
AF4-AF9 Value
NMR Distance and Dihedral Constraints
Distance constraints
Total NOE 2,168
Intraresidue 1,042
Interresidue 1,126
Sequential (ji – jj = 1) 529
Medium range (ji – jj < 4) 291
Long range (ji – jj > 5) 306
Intermolecular 76
Hydrogen bonds 22
Total dihedral angle restraints 116
f 59
c 57
Structure Statistics
Violations (mean and SD)
Distance constraints (A˚) 0.024 ± 0.004
Dihedral angle constraints () 0.91 ± 0.167
Maximum dihedral angle violation () 7.5
Maximum distance constraint violation (A˚) 0.517
Deviations from idealized geometry
Bond lengths (A˚) 0.003 ± 0.000
Bond angles () 0.47 ± 0.012
Impropers () 0.36 ± 0.03
Average pairwise rmsda (A˚)
Heavy 1.171
Backbone 0.572
Total RDCs
HN 49
Ca-C 41
Ca-Ha 32
RDCs used for validation but not for structure
calculation
HN 34
Qfree (%) 29.2
rmsd, root-mean-square deviation; RDC, residual dipolar coupling; HN,
the atom pair in the protein structure for which the RDC was measured.
aPairwise rmsd was calculated among 10 of 100 refined structures, over
residues 761–773 of AF4 and 502–562 of AF9.
Structure
AF9 AHD Is an Intrinsically Disordered Switch2C and 2D), which folds into a turn and packs behind the end of
the hairpin to form a key hydrophobic cluster. The last four struc-
tured residues (771–775) of AF4 make contacts with AF9,
although these are not as intimate as in the remainder of the
peptide. The interface between AF4 and AF9 is extensive and
hydrophobic, with a number of aliphatic residues from AF4
deeply buried in the hydrophobic core (Figures 2C and 2D).
Specifically, V763 and I765 pack into the interface of the hairpin
and the a1 and a3 helices, and they appear to stabilize the
tertiary fold of the complex. Specificity of AF4 binding also
appears to involve at least one electrostatic interaction, between
AF4 K764 and AF9 D544. The extensive hydrophobic interface178 Structure 21, 176–183, January 8, 2013 ª2013 Elsevier Ltd All rigbetween AF4 and AF9 may explain how the significant entropic
cost of folding of the complex can be overcome upon binding.
Clearly, the hydrophobic core of AF9 is not sufficiently extensive
to maintain an independently folded structure.
The AF9 AHD Recruits Multiple Partners through
Coupled Folding and Binding
In addition to AF4 family members, the AF9 AHD has previously
been shown to interact with hPC3, BCoR, and Dot1L. Having es-
tablished that AF4 and AF9 interact through mutual synergistic
folding, we hypothesized that other binding partners may
interact with AF9 in a similar manner.
The interactions of AF9 with its other binding partners have
been identified through a combination of coimmunoprecipitation
(Co-IP) and two hybrid experiments (Erfurth et al., 2004; Hemen-
way et al., 2001; Srinivasan et al., 2003; Zhang et al., 2006). It is
interesting that all of the sequences that interact with AF9 are in
regions of their respective proteins that were predicted to be
disordered by IUPred (Doszta´nyi et al., 2005) (Figure S1 available
online). We postulated that coexpression of these sequences
with AF9 using a bicistronic vector may allow us to validate
previous interaction studies and to finely map these interactions.
To check the feasibility of this approach, we coexpressed the in-
teracting regions of AF9 and AF4. This resulted in high expres-
sion of the AF4-AF9 complex, which was stable for extended
periods and produced high quality spectra (Figure 3A).
In order to investigate the other interactions with the AF9 AHD,
we cloned DNA coding for the sequences derived from hPC3,
Dot1L, and BCoR into our coexpression vector and found that
all of these copurified with AF9. Using triple-resonance-based
backbone assignments and [1H-15N] heteronuclear NOE experi-
ments, we were able to map the residues of these proteins
involved in the interaction with the AF9 AHD. Immediately
apparent is the similarity in the chemical shifts of the AF9 NH
moieties observed in the HSQC spectra of these complexes.
As chemical shifts are highly sensitive to structure, this similarity
indicates that AF9 retains a similar fold in all of the complexes
(Figures 3A–3D). Alignment of the sequences of AF9 binding
partners shows that, although there is little sequence conserva-
tion between the binding partners, there is a consensus
sequence that includes the buried aliphatic residues from AF4,
corresponding to L761, V763, and I765 (Figure 3G). Additionally,
each of the binding partners has two aliphatic residues in the
positions occupied by leucines 767 and 770 of AF4, which
form a turn in the AF4-AF9 complex. Comparison of these
spectra show that the characteristically downfield shifted peaks
corresponding to the beta strand in the AF4-AF9 spectra are
also present in the other complexes (labeled 1–3), suggesting
that the beta strand is common to each of the different
complexes. It is interesting that the plot of normalized chemical
shift differences in comparison to AF4-AF9 shows that the
chemical shifts of peaks from AF9 are remarkably similar in
each of the complexes, with the largest deviations in residues
adjacent to the AF4 binding site. These are along the b2 strand,
along loop 1 of AF9, and also in the a2 helix, which contains
a number of aliphatic residues that are involved in packing with
the buried residues of AF4. Despite having significantly different
sequences, the AF9 binding partners also share similar chemical
shifts, particularly through the conserved beta strand. Together,hts reserved
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Figure 2. Structure of the AF4-AF9 Complex
(A) Cartoon representation of the AF4-AF9
complex.
(B) Ensemble of the 10 lowest energy conformers.
AF4 is shown in blue, and AF9 is shown in red. The
AF4 peptide forms a third strand with the beta hair-
pin from AF9, which folds around the AF4 peptide.
(C and D) The AF4-AF9 interface. The Ca trace of
AF4 is shown as an orange ribbon. Hydrophobic
residues from AF4 are in khaki. AF9 surface is
colored according to electrostatic potential.
Hydrophobic residues from the AF4 strand (L761,
V763, and I765) penetrate deeply into the AF9
core. Asp 544 makes an electrostatic interaction
with Lys 764, which is shown in blue. (D) is (C)
rotated 90.
See Molecular Structure S1.
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AF9 AHD Is an Intrinsically Disordered Switchthese data strongly suggest that AF9 retains a similar fold in each
of the complexes and that each of its binding partners share
a common binding site on AF9. This is consistent with previous
data showing that AF9 binding partners interact with the AF9
AHD in a mutually exclusive manner (Srinivasan et al., 2003; Yo-
koyama et al., 2010). It was previously proposed that, where
intrinsically disordered proteins (IDPs) compete for binding to
a common site, coupled folding and binding may allow one
IDP to displace another without its prior dissociation, facilitating
rapid exchange between high affinity partners (De Guzman et al.,
2004). The differing functions of the AF9 binding partners
suggest that the function of the AHD may be to regulate gene
expression through alternate binding to its partners, and intrinsic
disorder may facilitate their exchange as a function of local
concentration and affinity.
The differences in sequence between the AF9 binding partners
prompted us to determine how this affects their affinities for AF9
and, presumably, their binding in vivo. Our efforts were severely
hampered by the hydrophobic nature of the isolated AHD and
the propensity of the peptides to aggregate in a number of condi-
tions tested. Expression of the AF9 AHD as a fusion to the
maltose binding protein (MBP) dramatically increased the solu-
bility of the domain and was critical for determining binding affin-
ities by fluorescence anisotropy. The affinity for AF4 is extremely
high (KD = 0.17 ± 0.05 nM) (Figure S2). A similarly high affinity was
observed for Dot1L (1.6 ± 0.3 nM) and BCoR (32 ± 20 nM);
however, the peptide from hPC3 binds with much lower affinity
(KD > 0.9 mM). The hPC3 sequence lacks a buried valine residue
that is part of the consensus sequence (Figure 3G) and that, we
hypothesized, may be responsible for the lower affinity. Intro-
duction of a valine at position 335 in the hPC3 peptide decreased
the dissociation constant between AF9 and hPC3 to 8.7 ± 0.7 nM
(Figure S2), demonstrating that this is indeed the case.Structure 21, 176–183, January 8, 2013Dynamics of the AF9-AF4 Complex
Assessed by 15N Backbone
Relaxation Measurements
The AF4 peptide is integral to the fold of
the AF4-AF9 complex, so exchange
between binding partners would require
significant structural rearrangements.
We therefore hypothesized that the AF4-AF9 complex may retain some conformational entropy in order
to reduce the activation energy for exchange, and that this
may be reflected in the backbone dynamics of the AF4-AF9
complex. To investigate this, we measured 15N longitudinal
(R1) and transverse (R2) relaxation rates for the coexpressed
AF4-AF9 complex as well as [1H-15N] heteronuclear NOE values
for the AF4-AF9 fusion (Figures 4A–4C). In order to analyze back-
bone dynamics, we calculated the product of R1 and R2, which
largely results in cancellation of the effects of anisotropic
motions on nuclear relaxation, and allows direct evaluation of
both slow and fast timescale motions (Figure 4D) (Kneller et al.,
2002). Conformational exchange on the ms-ms timescale results
in elevation of the R1R2 product, whereas fast exchange (ps-ns),
results in decreased R1R2. Deviation of R1R2 products from
a trimmed mean are shown on the AF4-AF9 structure in Fig-
ure 4E, with depressed values, corresponding to ps-ns timescale
motions in red, and elevated values, corresponding to ms-ms
timescale motions, in blue.
Several loops, particularly those near the AF4 peptide, are
involved in conformational exchange. One of these is the loop
formed by residues 539–542 at the tip of the hairpin, which is
adjacent to the turn formed by AF4 residues 767–770. Another
is the preceding loop formed by residues 531–535, which makes
contact with the C-terminal residues of AF4. More important, the
strand formed by AF9 residues 761–765 and parts of the helix
adjacent to it exhibit dynamic behavior on a fast (nanosecond
to picosecond) time scale, which has been shown to correlate
with side chain conformational entropy (Gagne´ et al., 1998). It
is interesting that the methyl resonances in the core of the
protein, particularly those adjacent to the aromatic rings of AF9
F543 and F545, show surprisingly poor chemical shift dispersion,
suggestive of internal dynamics within the hydrophobic core.
Further support for this comes from thermal equilibriumª2013 Elsevier Ltd All rights reserved 179
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Figure 3. Comparison of AF9 in Complex
with Four Binding Partners
(A–D) HSQC spectra of (A) AF4-AF9, (B) Dot1L-
AF9, (C) hPC3-AF9, and (D) BCoR-AF9. Circles
show peaks corresponding to conserved residues
in (G). Dashed boxes show position of peaks from
AF4-AF9.
(E and F) Normalized chemical shift differences
from AF4-AF9 are shown in colors corresponding
tospectra, in (E) forAF9and (F) forbindingpartners.
(G) Aligned sequences of interacting peptides.
See also Figures S1 and S2.
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AF9 AHD Is an Intrinsically Disordered Switchunfolding measurements monitored by far UV CD (Figure 4). We
were unable to achieve complete unfolding, even at 95C,
consistent with the high affinity of the AF4 peptide for AF9. It is
important to note that AF4-AF9 unfolds with a broad transition,
quite different from the highly cooperative transitions observed
for rigid domains with stably packed hydrophobic cores. These
data suggest that aliphatic residues at the AF4-AF9 interface
retain a significant amount of conformational entropy, which
may partially compensate for the loss of conformational entropy
during coupled folding and binding and may be required for
dynamic exchange between binding partners.
DISCUSSION
AF9 has previously been shown to regulate a number of genes
with roles in development and lineage determination. Previous
studies suggest that AF9 and ENL function downstream of
MLL to regulate transcriptional elongation, and the distinct180 Structure 21, 176–183, January 8, 2013 ª2013 Elsevier Ltd All rights reservedfunctions of the AF9 binding partners
suggest a direct role of AF9 in regulation
of elongation by promoter proximally
paused RNA PolII. We propose that the
intrinsically disordered nature of the AF9
AHD and its binding partners is pivotal
for integration of signaling mechanisms
and transcriptional control at develop-
mentally regulated loci.
Intrinsic disorder conveys a number of
important kinetic advantages for protein
interactions in signaling networks and in
transcriptional regulation (Pontius, 1993;
Shoemaker et al., 2000). In addition to
providing fast association kinetics, it
was also proposed that intrinsic disorder
may facilitate displacement of one IDP
by another from an overlapping binding
site without its complete prior dissocia-
tion and, as such, binding would be
controlled by mass action (De Guzman
et al., 2004).
For AF9, where the binding partners
have discrete functions, thismay facilitate
integration of signaling networks through
response to local concentrations of
proteins, posttranslational modifications,and alternative splicing. Of the AF9 binding partners, the AF9
interaction motif from BCoR is only present in specific isoforms.
This suggests that alternative splicing may be a mechanism for
regulation of AF9-mediated transcriptional control in a tissue-
specific or developmentally regulated manner. Similarly, AF4
and hPC3 contain phosphorylation sites within the AF9 con-
sensus binding sequence, which may allow transient and
reversible regulation of these interactions. For instance, phos-
phorylation of T766 of AF4 results in an 30-fold reduction of
its affinity for AF9 (Figure S2E). It is interesting that AF4 is also
targeted for proteosomal degradation in the absence of binding
to AF9 or ENL which would reduce the global concentration of
AF4 and downregulate transcriptional elongation (Bitoun et al.,
2007). Posttranslational modifications may also increase the
avidity of these interactions and stabilize binding of a partner in
a regulatedmanner. The interaction of hPC3with AF9 is relatively
weak; however, the increased avidity imparted through binding
of the hPC3 chromodomain to H3K27me3 may be sufficient to
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Figure 4. Dynamics of the AF4-AF9
Complex
(A–D) R1, R2, and R13 R2 values for coexpressed
AF4-AF9 are shown in (A), (C), and (D), respec-
tively. Heteronuclear NOE for the AF4-AF9 fusion
used for structure determination is shown in (B).
The dashed line in (D) shows a 10% trimmed mean
for R1 3 R2 after exclusion of values < 0.65. Error
bars represent the fitted error for the R1 and R2
measurements propagated to the R13 R2 values.
(E) Deviation of R1 3 R2 products from the trim-
med mean. Depressed values (fast exchange) are
in red; elevated values (slow exchange) are in blue.
(F) Far-UV CD spectra of coexpressed AF4-AF9
recorded at 10C increments from 25C to 95C.
Insert: average molar ellipticity at 222 nm as
a function of temperature.
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AF9 AHD Is an Intrinsically Disordered Switchprevent displacement of hPC3 by other partners, resulting in
stable transcriptional silencing.
The potential role for intrinsic disorder of the AF9 binding part-
ners in enhancing exchange is clear, but the reason for the intrin-
sically disordered nature of AF9 is less clear. A frequently
observed facet of molecular recognition through coupled foldingStructure 21, 176–183, January 8, 2013and binding is the high specificity
afforded through the extensive interface
formed between the IDP and its inter-
action partner (Spolar and Record,
1994).The aliphatic side chains of AF4
form an integral part of the hydrophobic
core of the AF4-AF9 complex, generating
an extensive hydrophobic interface.
However, globular proteins are largely
stabilized by van der Waals contacts
from close packing of hydrophobic
side chains, and their unfolding initially
requires unlocking of this core with an
associated increase in side chain confor-
mational entropy to form a dry molten
globule intermediate (Baldwin et al.,
2010). Therefore, if the AF4-AF9 complex
exhibited the same close packing interac-
tions as globular proteins, unlocking of
the protein core would represent a signifi-
cant free energy barrier to the exchange
between binding partners. It is likely that
retention of conformational entropy in
the core of the AHD, reflected in the 15N
backbone relaxation data, may reduce
the free energy barrier for exchange
between high affinity binding partners.
Correspondingly, the lack of an optimally
packed core may result in the absence of
independent folding of the AHD. Through
formation of a slightly fuzzy complex
(Tompa and Fuxreiter, 2008), it may there-
fore be possible to retain both high affinity
binding, coupled with a low energy barrier
for exchange in response to changes inprotein concentrations or modifications. Such behavior is likely
to be important for regulation of developmentally critical genes
that must be turned on or off with high fidelity but in a rapid
and synchronous manner.
Control of transcriptional elongation through release of
promoter proximally paused RNA PolII allows rapid and highlyª2013 Elsevier Ltd All rights reserved 181
Structure
AF9 AHD Is an Intrinsically Disordered Switchsynchronous induction of transcription in processes such as
cellular differentiation and embryonic patterning as well as in
the heat shock response (Boettiger and Levine, 2009). At
HSP70 loci, this is stimulated through sequential recruitment of
transcription factors (Zobeck et al., 2010). Intrinsic disorder in
the AF9 AHD and its partners may facilitate this sequential
recruitment to repress or activate transcription in a highly regu-
lated manner. For instance, MLL regulates transcriptional initia-
tion through methylation of H3K4 and recruitment of CBP/
p300. AF9 or ENL may then stabilize promoter proximal pausing
through recruitment of BCoR to deacetylate H3K27. Trimethyla-
tion of H3K27 would increase binding avidity of hPC3 resulting in
a stably repressed but poised promoter. Conversely, H3K79
methylation has been proposed to antagonize epigenetic
silencing, and so we envisage that Dot1L may be recruited to
inhibit polycomb-mediated silencing, either before or after
release of RNA PolII pausing by recruitment of P-TEFb by AF4.
Direct fusion of AF9 toMLL results in loss of context dependence
of AF9 recruitment, and the high affinity of AF4 for AF9 suggests
that this may dominate binding to MLL-AF9, leading to the upre-
gulation of HOXA9 and MEIS1 and, ultimately, to leukemia.
EXPERIMENTAL PROCEDURES
Protein Preparation and Construct Design
For initial studies of the AF9 AHD, we expressed residues 490–568 of AF9 from
pET 32a (Novagen) with the region coding for thioredoxin removed. Proteins
were purified using Ni-NTA agarose and size exclusion chromatography. To
prepare a saturated sample of AF9 bound to the minimal AF4 peptide, the
peptide was added to a dilute sample of purified AF9 AHD and incubated at
room temperature overnight. The sample was concentrated by ultrafiltration,
and the complex was purified by size exclusion chromatography.
The AF4-AF9 fusion included an N-terminal 6-His tag and TEV protease site,
with the coding sequence for AF4 residues 738–779 directly fused to AF9 resi-
dues 490–568 in pET 32a (Novagen). Proteins were expressed in Rosetta2DE3
cells (Novagen) in European Molecular Biology Laboratory medium supple-
mented with 10 ml/l of Bioexpress (Cambridge Isotopes), where necessary
substituting with isotopically labeled bioexpress, 15N-labeled ammonium
sulfate, or 13C-labeled glucose. Proteins were purified by Ni-NTA chromatog-
raphy, purification tags were removed by digestion with Enterokinase (AF9
AHD) (New England Biolabs [NEB]) or TEV protease (AF4-AF9), and aggre-
gates and impurities were removed by gel filtration chromatography using
a Superdex 75 column (GE Life Sciences).
Coexpression constructs were generated by cloning DNA coding for AF9
residues 500–568 and for binding partners into pET Duet 1 modified by addi-
tion of a TEV cleavage site between the His tag and the fusion partner. Proteins
were expressed and purified as for the AF4-AF9 fusion. Residues that re-
mained rigid in the complex were identified using assignments from HNCACB
and CBCA(CO)NH experiments and heteronuclear NOE experiments per-
formed as detailed in the Supplemental Experimental Procedures.
CD Experiments
CD samples were exchanged into 10 mM potassium phosphate, 10 mM NaCl,
0.5 mM dithiothreitol (DTT) at the gel filtration step. CD experiments were con-
ducted with 3.7 mM AF9 or 9.4 mM AF4-AF9, and data were collected at 1 nm
intervals with 3 s averaging time. Melting experiments were conducted with
20 mM coexpressed AF4-AF9. Spectra are shown as an average of 16 scans.
All data were collected on an Aviv 410 spectropolarimeter.
Fluorescence Anisotropy Binding Experiments
DNA coding for AF9 residues 475–568 of mouse AF9 were cloned into pMAL
C2 (NEB) and the protein expressed in Rosetta2DE3 cells in LB medium.
MBP-AF9 was purified on Amylose resin (NEB) and impurities and aggregates
removed immediately by size exclusion chromatography. Proteins were182 Structure 21, 176–183, January 8, 2013 ª2013 Elsevier Ltd All rigtitrated into 0.5 nM (AF4) or 1nM (BCoR, hPC3 or Dot1L) peptide in 50 mM
Tris-HCl, 50 mM NaCl, 1 mM DTT, 1 mM EDTA, pH 8.5 and incubated for
1 hr at room temperature. Anisotropymeasurements were recorded on a Pher-
astar plate reader. Data were fitted to a single site binding model accounting
for ligand depletion (Veiksina et al., 2010).
NMR Methods and Structure Determination
Full details of NMR methods are included in the Supplemental Experimental
Procedures.
All NMR experiments for initial structure determination were conducted with
a 0.6 mM sample of AF4-AF9 in 25 mM Bis-Tris/MES pH 6.0, 100 mM NaCl,
1 mM DTT at 25C.
ACCESSION NUMBERS
The PDB accession number for the AF4-AF9 structure reported in this paper is
2LM0, and NMR data were deposited in the BMRB under accession number
18094.
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Supplemental information includes two figures, one molecular structure, and
Supplemental Experimental Procedures and can be found with this article on-
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